Two cases of typical left ventricular cardiac echinococcosis: a retrospective review with literature synthesis Authors: Xinqi Xu, Xiaohan Xu, Yongfeng Shao, Faliang Zhan, Tao Ye, Cong Zhang, Rui Liu, Chunyuan Shen, Miti Wu Published: 2026 ABSTRACT Echinococcus granulosus is a cestode parasite responsible for zoonotic hydatid disease. Humans acquire the infection by ingesting water or food contaminated with viable eggs, thereby serving as intermediate hosts. Although the liver and lungs are the organs most frequently involved, cardiac involvement is rare and often clinically silent. The majority of patients seek medical attention due to symptoms of organ compression. At present, the standard management combines surgical removal with perioperative antiparasitic chemotherapy. Here we report two illustrative cases of cardiac echinococcosis involving the left ventricular wall and integrate them with previously published data to provide a comprehensive review of the diagnosis and treatment of cardiac echinococcosis. This review summarizes the key points throughout the entire treatment process of cardiac echinococcosis. Background Hydatid disease is a parasitic infection endemic to pastoral regions. When a fertile hydatid cyst is ingested by a dog, the protoscolex evaginates and develops into an adult tapeworm in the small intestine. The disease is prevalent in Mediterranean littoral countries, the Middle East, Central Asia, Western China, Australia and South America [1]. An estimated 1–3 million new human infections occur annually [2]. Dogs and other canids serve as definitive hosts, sheep as the usual intermediate host, and humans are accidental intermediate hosts after ingesting water or food contaminated with embryonated eggs [3]. In humans the parasite most frequently establishes in the liver and lungs [4], producing cystic lesions that may become symptomatic because of mass effect or, occasionally, cause anaphylaxis or death after rupture. Cardiac echinococcosis (CE) is a rare manifestation, accounting for 0.5–2% of all cases [5]. If the patient with CE does not receive adequate treatment, the disease can be lethal [6]. The left ventricular wall is the most common cardiac site (60%), followed by the right ventricle (10%), pericardium (7%), left atrium (6–8%), right atrium (4%) and interventricular septum (4%) [7]. Patients may be asymptomatic or present with chest pain, arrhythmia, heart failure or life-threatening complications secondary to compression of coronary arteries or the conduction system. Clinicians may also notice possible illnesses such as coronary artery displacement, cardiac arrhythmia or ventricular dysfunction due to the variety of symptoms in this disease [8]. Main text Case presentation Case 1 A 36-year-old herdsman presented with epigastric pain and nausea that had persisted for two months. Two years earlier he had experienced identical complaints; contrast-enhanced computed tomography (CT) at that time had disclosed multiple hypodense cystic lesions in the left ventricular myocardium, right middle lobe of the lung, spleen, and both hepatic lobes. The largest cyst, located in the right lobe of the liver, measured 70 mm; the left ventricular cyst was 40 mm; all remaining lesions were ≤ 30 mm. A diagnosis of disseminated hydatidosis was made. In April 2020 the patient underwent laparoscopic hepatic surgery at a local hospital; two cysts were removed from the left lobe of liver and right lobe of liver, but lesions in other organs were left in situ. Postoperatively his symptoms resolved, but he did not receive regular albendazole therapy. Twenty months later the pain and nausea recurred. Chest radiography and electrocardiogram (ECG) were unremarkable. Follow-up CT examination demonstrated multiple new cystic lesions involving the left hepatic lobe, spleen, subdiaphragmatic space, left ventricle, and right middle lobe of the lung. A well-circumscribed, ovoid cystic lesion with a peripheral hyperdense rim was noted in the posterior left ventricular wall, measuring 36.0 × 47.0 × 60.0 mm (transverse × longitudinal × anteroposterior dimensions). An additional cystic lesion within the right middle lobe measured 10.5 × 12.7 × 15.2 mm (Fig. 1). MRI utilizing an FS Double IR black-blood sequence demonstrated a cystic lesion in the left ventricular lateral wall on the four-chamber view (Fig. 2A). Short-axis images, acquired perpendicular to the interventricular septum in the LV long-axis plane using the four-chamber view as a localizer, revealed the ovoid lesion to be hyperintense with a surrounding hypointense rim (Fig. 2C-D). Echocardiography demonstrated an intramyocardial cystic lesion within the left ventricular lateral wall, measuring approximately 5.9 × 3.9 cm. The lesion was well-circumscribed, mildly irregular in shape, thick-walled, and anechoic (Fig. 2B). The findings, together with the previous history, established a diagnosis of recurrent Echinococcus granulosus infection, and the patient was admitted to our unit. After multidisciplinary discussion a staged operative plan was adopted, prioritizing thoracic intervention. A median sternotomy was performed and the pericardium opened; the anterior mediastinum and pericardial cavity were meticulously inspected for minute cysts. Cardiopulmonary bypass (CPB) was instituted with ascending aortic cannulation and bicaval venous drainage; core temperature was lowered to 31 °C. After aortic cross-clamping, cold blood cardioplegia was delivered via the aortic root. The heart was elevated to the right, revealing a 6 × 7 cm bulge in the upper lateral left ventricle. The operative field was isolated with hypertonic saline packs. A wide-bore needle was inserted and cyst fluid aspirated; 20% hypertonic saline was instilled and left for 5 min to kill the parasite. The cyst wall was then incised longitudinally, the saline evacuated, and the germinative membrane together with multiple daughter cysts removed intact (Fig. 3). The residual cavity was thoroughly irrigated with hypertonic saline and carefully inspected for diverticula, small residual cysts, or communications with the left ventricular cavity; none were found. The myocardial incision was closed with a continuous absorbable suture. The aortic clamp was released and the heart resumed sinus rhythm; the patient was weaned from bypass without difficulty. The right pleura was opened and a wedge resection of the right middle lobe cyst performed. Histopathology of both the myocardial and pulmonary specimens confirmed E. granulosus infection. The postoperative course was uneventful; the patient was discharged on day 6 on albendazole 400 mg daily. Two months later he was transferred to the general surgery service of another hospital where splenectomy and removal of hepatic and subdiaphragmatic cysts were completed. Albendazole was continued for a total of six months. Follow-up echocardiography and CT (Fig. 5A) shows complete closure of the residual cyst cavity and no residual or recurrent cystic disease in the chest or abdomen; the patient remains asymptomatic. Fig. 1Repeat CT images. A, An oval low-attenuation lesion with a hyper-dense rim is seen in the posterior left-ventricular wall (white asterisk). B, A second oval low-attenuation lesion is present adjacent to the oblique fissure in the right middle lobe (white triangle) Repeat CT images. A, An oval low-attenuation lesion with a hyper-dense rim is seen in the posterior left-ventricular wall (white asterisk). B, A second oval low-attenuation lesion is present adjacent to the oblique fissure in the right middle lobe (white triangle) Fig. 2MRI and echocardiography. A, C, D Cardiac MRI of the posterior left-ventricular lesion: hyper-intense on FS Double IR black-blood imaging with a peripheral hypo-intense rim; bright hyper-intensity on Fiesta cine bright-blood sequence; no enhancement on post-contrast GR (white asterisk). B, Apical four-chamber view: hypoechoic area in the left ventricular lateral wall MRI and echocardiography. A, C, D Cardiac MRI of the posterior left-ventricular lesion: hyper-intense on FS Double IR black-blood imaging with a peripheral hypo-intense rim; bright hyper-intensity on Fiesta cine bright-blood sequence; no enhancement on post-contrast GR (white asterisk). B, Apical four-chamber view: hypoechoic area in the left ventricular lateral wall Fig. 3Intra-operative photographs. A-B, Germinative membrane and multiple daughter cysts removed through a left-ventriculotomy Intra-operative photographs. A-B, Germinative membrane and multiple daughter cysts removed through a left-ventriculotomy Case 2 A 64-year-old woman was referred after a routine health check disclosed an intracardiac mass. She had lived for decades in a pastoral area and reported occasional mild palpitations during the preceding three months; chest radiography and ECG were normal. Transthoracic echocardiography (TTE) revealed a 6.0 × 4.8 cm mass attached to the inferior left ventricular wall. Subsequent cardiac MRI demonstrated a well-circumscribed, multiloculated cyst on the two-chamber view, which appeared hypointense on T1-weighted imaging and hyperintense on T2-weighted imaging (Fig. 4A). Contrast-enhanced CT demonstrated a 7.0 × 5.5 cm hypodense polycystic lesion in the apical-inferior left ventricular wall. Taken together with her epidemiologic background, the findings strongly suggested cardiac hydatidosis, and surgery was scheduled. Through a median sternotomy the pericardium was opened; the anterior mediastinum and pericardial cavity were carefully inspected for minute satellite cysts. CPB was instituted with ascending-aortic cannulation and bicaval venous drainage; core temperature was lowered to 32 °C. After aortic cross-clamping, cold blood cardioplegia was delivered via the aortic root. A firm 8 × 7 cm bulge was identified on the diaphragmatic surface of the left ventricle (Fig. 4C); the overlying pericardium was densely adherent. The adhesions were dissected, a portion of involved pericardium excised, and the heart elevated to the right. The field was isolated with hypertonic-saline packs. A wide-bore needle was inserted and cyst fluid aspirated; 20% hypertonic saline was instilled and retained for 5 min to kill the parasite. The cyst wall was then incised longitudinally, the saline evacuated, and the germinative membrane together with numerous daughter cysts removed intact. The residual cavity was thoroughly irrigated with hypertonic saline (Fig. 4D) and meticulously examined for diverticula, small residual cysts, or communications with the left ventricular cavity; none were found. The myocardial defect was closed in two layers with continuous 4 − 0 Prolene sutures. The aortic clamp was released and the heart resumed sinus rhythm; the patient was weaned from bypass without difficulty. The post-operative course was uneventful. Histopathology of the surgical specimen confirmed Echinococcus granulosus infection. The patient was discharged on post-operative day 6 on albendazole 400 mg daily, which was continued for six months. One-year follow-up echocardiography and CT (Fig. 5B) showed no residual or recurrent disease; she remains asymptomatic. Fig. 4MRI and CT images and Intra-operative photographs. A, Cardiac MRI shows a well-circumscribed, heterogeneous intramyocardial mass. B, Cardiac CT reveals a large intramyocardial cystic mass (7.0 × 5.5 cm) in the inferior wall near the left-ventricular apex. C, Global view of the mass on the diaphragmatic surface of the left ventricle. D, Large residual cavity after removal of the germinative membrane and daughter cysts MRI and CT images and Intra-operative photographs. A, Cardiac MRI shows a well-circumscribed, heterogeneous intramyocardial mass. B, Cardiac CT reveals a large intramyocardial cystic mass (7.0 × 5.5 cm) in the inferior wall near the left-ventricular apex. C, Global view of the mass on the diaphragmatic surface of the left ventricle. D, Large residual cavity after removal of the germinative membrane and daughter cysts Fig. 5 Postoperative follow-up CT images of the patients. A, B Postoperative follow-up CT images of the two patients showed no residual or recurrent disease Postoperative follow-up CT images of the patients. A, B Postoperative follow-up CT images of the two patients showed no residual or recurrent disease Discussion Hydatid disease most commonly affects the liver and lungs; cardiac involvement is extremely rare. CE usually results from rupture of a pulmonary cyst, with scolices reaching the myocardium via the coronary arteries or the pulmonary veins. Every cardiac chamber can be involved, yet the left ventricle is by far the most frequently affected site [9, 10], as illustrated by the two patients reported here. The parasite may also settle in the pericardium and the myocardial wall [10]. The predilection for the left ventricle is generally attributed to the predominance of the left coronary circulation [11]. Cardiac echinococcosis initially invades the myocardium via the left-sided coronary circulation, often through arterial emboli formation in the left anterior descending artery [12]. As a major coronary branch, the left anterior descending artery supplies the anterior left ventricular wall, the anterior two-thirds of the interventricular septum, and the cardiac apex. Consequently, the disease frequently involves the free wall of the left ventricle, leading to a predominant involvement of the left ventricular wall and interventricular septum. Cardiac hydatidosis can present at any age and its clinical spectrum is wide. Patients may be asymptomatic or may develop heart failure, cardiac tamponade, pulmonary embolism, stroke, atrioventricular block, paroxysmal supraventricular tachycardia, mitral regurgitation, pericardial effusion, coronary artery disease, anaphylaxis, or sudden death [13]. The precise manifestations depend on the cyst’s location, size, and the structures it compresses or invades. When the conduction system is involved, various degrees of atrioventricular block may ensue. Cysts embedded in the left ventricular myocardium are usually subepicardial; rupture into the pericardial space can trigger inflammatory pericarditis, and a large resultant effusion may produce life-threatening tamponade [14, 15]. As observed in the present report, chest pain, dyspnoea and palpitations are the most common complaints, probably reflecting coronary compromise or impending tamponade [16] and further explaining why the left ventricle is so often involved. It is noteworthy that, despite symptomatic palpitations, the ECG frequently shows only sinus rhythm; thus the tracing cannot be relied upon to suggest CE. This limitation greatly increases diagnostic difficulty and underscores the decisive role of imaging modalities and serological tests in confirming the disease. TTE offers high sensitivity and specificity for the diagnosis of CE [17, 18]. As illustrated by our second patient, a typical cystic CE lesion appears on echo as a sharply circumscribed echogenic structure that must be distinguished from a myxoma; hyper-echogenic areas usually indicate inspissation, calcification or degeneration of the cyst. A cardiothoracic ratio above normal is common, and the lesion may mimic an intracardiac mass [19, 20]. Subsequent CT and MRI are indispensable for definitive evaluation. Because CE is characteristically multi-organ, secondary involvement of—most commonly—the liver and lungs is almost inevitable [21]. Chest radiography and routine blood tests may therefore raise the initial suspicion in disseminated disease. Serology (indirect haemagglutination, enzyme-linked immunosorbent assay) is highly sensitive and specific for CE [21]; peripheral eosinophilia is occasionally detected. Nevertheless, the diagnostic accuracy of these laboratory tests, especially for isolated cardiac disease, has not been established; they are probably more useful for post-operative surveillance of recurrence. Surgery remains the only effective treatment for cardiac hydatidosis [22]. The catastrophic consequences of intra-operative rupture mandate that every cardiovascular hydatid cyst be treated as a surgical emergency [23, 24]. Pre-operative TTE, CT [25] and MRI [26, 27] are strongly recommended to assess ventricular function and any concomitant cardiac pathology. The value of pre-operative benzimidazole therapy (mebendazole or albendazole) is controversial. Unlike hepatic cysts, cardiac cysts—particularly those with thin walls—are prone to rapid rupture under the constant mechanical stress of the beating heart. Ohri et al. [28] argued that benzimidazoles may weaken the cyst wall and increase the risk of pre-operative rupture. Indeed, most cases are operated on electively without pre-treatment [29]; thus routine pre-operative benzimidazoles are not mandatory. Median sternotomy is the standard approach: it provides excellent exposure, allows search for small, pre-operatively undetected cysts, and permits simultaneous management of associated cardiopulmonary lesions [5]. CPB is advisable; it allows controlled evacuation of large residual cavities and treatment of concomitant lesions. The cyst must not be manipulated until the aorta is cross-clamped. Cannulation sites must be chosen carefully; when the right heart is involved, the right atrial entrance should be avoided and femoral cannulation is preferable. An arterial line filter should be inserted into the CPB circuit to trap any scolices inadvertently released [30]. If the lesion is in the right heart, the main pulmonary artery should be snared before manipulation to prevent fatal pulmonary embolism. After cardioplegic arrest the entire pericardial cavity must be re-explored. Unlike other cardiac operations, scolicidal treatment of the cyst cavity is a crucial step. Before the cyst is opened, the surrounding area is packed with hypertonic saline-soaked swabs. After the contents have been evacuated, the cavity is re-filled with a scolicidal agent: 20–33% hypertonic saline, 1% iodine solution or 0.5% silver nitrate are effective and safe [31]. Two-percent formalin and absolute alcohol may damage myocardium and the circulation and are therefore not recommended [5]. The residual cavity wall is carefully palpated for softness or thinning and meticulously inspected for daughter diverticula. The cavity must be obliterated to prevent post-operative false aneurysm or lethal ventricular rupture; linear closure with Teflon-felt reinforcement and biological glue may be helpful, taking care to avoid distortion of the ventricular geometry [31]. Because CPB is already in place, synchronous pulmonary hydatid cysts can be dealt with through a trans-pleural approach, whereas any other concomitant cardiac procedure should be deferred until after the hydatid lesion has been eradicated. Post-operative systemic chemotherapy is now widely accepted. Benzimidazoles (mebendazole, albendazole) reduce the risk of recurrence; albendazole is preferred because it is given in lower doses and is better absorbed. The WHO recommends mebendazole 40–50 mg/kg/day or albendazole 10–15 mg/kg/day [2]. Liver enzymes should be monitored during albendazole therapy [32]. Some authors advocate cyclic administration (10–12 mg/kg daily for 28 days, repeated for 3–4 cycles with 2-week drug-free intervals) [2]. For surgically accessible lesions, the WHO advises complete excision followed by at least two years of benzimidazole therapy, even in asymptomatic patients. Praziquantel has recently been proposed as an adjunct to albendazole in relapsing cases. For patients who refuse surgery or in whom CPB is contraindicated, albendazole alone remains the only option [33]. Barbetseas J et al. [34] reported three cases of cardiac echinococcosis, two of whom received conservative albendazole treatment due to inability to tolerate surgery or refusal of surgery. During the 1–2 year follow-up, no patient experienced recurrence, demonstrating the important therapeutic role of albendazole for such patients. Additionally, Stojkovic M et al. [35] conducted a systematic analysis of the efficacy of albendazole and other drugs for myocardial echinococcosis, which clearly indicated that albendazole has good therapeutic efficacy for active cysts, with 50–75% of active cysts becoming inactive or disappearing within 1–2 years after treatment. These findings further validate the critical importance of albendazole for patients who cannot undergo surgery. Long-term follow-up is mandatory [36, 37]. At 3 months post-discharge, a first follow-up echocardiography is routinely performed to evaluate early postoperative cardiac status. At 6 months of postoperative albendazole therapy, repeat echocardiography is performed to assess cardiac functional remodeling and monitor for early recurrence [38]. During the first five post-operative years, CT or MRI of the chest (and of the liver, lungs and brain—the most frequent secondary sites) is recommended annually. Serial serology may also help to identify relapse [39, 40]. Serologic tests such as the Casoni test are not very reliable, with false-positive and false-negative rates as high as 30%. The ELISA test demonstrates a sensitivity of 91% and a specificity of 82%. Indirect hemagglutination (IHA), indirect fluorescent antibody tests, and enzyme immunoassays (EIA) are sensitive methods for detecting antibodies in the serum of these patients, with sensitivity rates varying from 60% to 90% depending on case characteristics. Crude hydatid cyst (HC) fluid is generally employed as antigen. Currently, the best available serologic diagnosis is obtained through combinations of tests: EIA or IHA are used to screen all specimens, and a positive reaction is confirmed by immunoblot assay or any gel diffusion assay that demonstrates the echinococcal “Arc 5” [41]. Meanwhile, we have reviewed the relevant literature and found that few reports on cardiac echinococcosis have correlated serial serological analysis with echocardiographic findings. Therefore, we recommend performing concurrent serological testing as a diagnostic adjunct during echocardiographic follow-up of cardiac function. The proposed timeline includes examinations at 1 month, 3 months, and 6 months post-discharge, followed by regular follow-up every 6 months if the condition shows no significant changes. We are also interested in exploring whether a correlation exists between these two modalities, and we plan to incorporate this analysis in future cases. We look forward to this approach potentially providing a basis for detecting disease recurrence.CE is rare but potentially serious. Nevertheless, with timely diagnosis and appropriate surgical and medical management, it is no longer associated with high mortality. In the pooled literature, no deaths were directly attributable to the cardiac lesions themselves; intra-operative cyst rupture, pulmonary embolism and multi-organ failure were the principal causes of death [42]. Conclusion In summary, surgery remains the gold-standard treatment for CE. We recommend routine cardiac screening of high-risk populations to enable early detection. Standardized, optimized peri-operative management maximizes surgical success and minimizes potentially fatal complications. Post-operative pharmacotherapy should be administered routinely. By presenting two typical cases of left-ventricular-wall hydatidosis, we conducted a retrospective review of existing treatment strategies and relevant reported literature, hoping to provide a practical template for the standardized management of CE. We trust that these illustrations will facilitate earlier recognition and more effective surgical therapy of this uncommon disease.